AVMXF

Avita Medical Ltd.

 
Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: MCAP LLC
Verified Company Profile 8/14/2017
Contact Info
  • 28159 Avenue Stanford
  • Suite 220
  • Valencia, CA 91355

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Sep 30, 2017 Quarterly Report
CIK 0001541697
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: Australia
Year of Inc. 2008
Employees 41 a/o Aug 11, 2017
Company Officers/Contacts
Michael Perry CEO, Executive Director
Timothy Rooney CFO
Company Directors
Lou Panaccio Chairman
Jeremy Curnock Cook Non-Executive Director
Louis Drapeau Non-Executive Director
Suzanne Crowe Non-Executive Director
Company Notes
  • Sponsored for OTCQX by Roth Capital Partners, LLC on 3/29/2012.
  • Formerly=Clinical Cell Culture, Ltd. until 5-2009
  • Formerly=Ecat Development Capital Ltd. until 9-03
Service Providers
OTCQX Advisor
MCAP LLC
1633 Broadway 28th Floor
New York, NY, 10019
USA

Accounting/Auditing Firm
Grant Thornton
Level 1
10 Kings Park Road
West Perth, WA, 6005
Australia

Legal Counsel
Steinepreis Paganin Lawyers & Consultants
Level 4, The Read Buildings
16 Milligan Street
Perth, WA, 6000
Australia

Clifford Chance
31W 52nd Street
New York, NY, 10019
United States

Investor Relations Firm
Not Available
AVMXF Security Details Other Company Securities
Share Structure
Market Value1 $37,700,312 a/o Dec 15, 2017
Authorized Shares 838,989,992 a/o Aug 30, 2016
Outstanding Shares 673,219,854 a/o Dec 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
AVH - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 1,138,676 (361.48%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security